PacificHealth Laboratories Return On Equity vs. Total Debt

Based on PacificHealth Laboratories' profitability indicators, PacificHealth Laboratories may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess PacificHealth Laboratories' ability to earn profits and add value for shareholders.
For PacificHealth Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PacificHealth Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PacificHealth Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PacificHealth Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PacificHealth Laboratories over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Please note, there is a significant difference between PacificHealth Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if PacificHealth Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PacificHealth Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PacificHealth Laboratories Total Debt vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PacificHealth Laboratories's current stock value. Our valuation model uses many indicators to compare PacificHealth Laboratories value to that of its competitors to determine the firm's financial worth.
PacificHealth Laboratories is considered to be number one stock in return on equity category among its peers. It also is rated top company in total debt category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value PacificHealth Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for PacificHealth Laboratories' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

PacificHealth Total Debt vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

PacificHealth Laboratories

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.75
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

PacificHealth Laboratories

Total Debt

 = 

Bonds

+

Notes

 = 
54.86 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

PacificHealth Total Debt vs Competition

PacificHealth Laboratories is rated top company in total debt category among its peers. Total debt of Consumer Staples industry is at this time estimated at about 2.05 Million. PacificHealth Laboratories holds roughly 54,860 in total debt claiming about 2.68% of stocks in Consumer Staples industry.
Total debt  Revenue  Capitalization  Valuation  Workforce

PacificHealth Laboratories Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in PacificHealth Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PacificHealth Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of PacificHealth Laboratories' change in net profit over the period of time. It can combine multiple indicators of PacificHealth Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey. Pacifichealth Laboratories operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 8 people.

PacificHealth Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PacificHealth Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PacificHealth Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PacificHealth Laboratories' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in PacificHealth Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Use Investing Themes to Complement your PacificHealth Laboratories position

In addition to having PacificHealth Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Mid Cap ETFs Thematic Idea Now

Mid Cap ETFs
Mid Cap ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in PacificHealth Pink Sheet

If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities